SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-014904
Filing Date
2022-08-05
Accepted
2022-08-04 19:15:05
Documents
70
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q akro-20220630.htm   iXBRL 10-Q 3259221
2 EX-10.2 akro-ex10_2.htm EX-10.2 661028
3 EX-10.3 akro-ex10_3.htm EX-10.3 186619
4 EX-10.4 akro-ex10_4.htm EX-10.4 183833
5 EX-31.1 akro-ex31_1.htm EX-31.1 21210
6 EX-31.2 akro-ex31_2.htm EX-31.2 20875
7 EX-32.1 akro-ex32_1.htm EX-32.1 18685
  Complete submission text file 0000950170-22-014904.txt   11558070

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT akro-20220630.xsd EX-101.SCH 50547
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT akro-20220630_lab.xml EX-101.LAB 435154
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT akro-20220630_cal.xml EX-101.CAL 40430
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT akro-20220630_pre.xml EX-101.PRE 323706
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT akro-20220630_def.xml EX-101.DEF 167264
64 EXTRACTED XBRL INSTANCE DOCUMENT akro-20220630_htm.xml XML 2059546
Mailing Address 601 GATEWAY BOULEVARD, SUITE 350 SOUTH SAN FRANCISCO CA 94080
Business Address 601 GATEWAY BOULEVARD, SUITE 350 SOUTH SAN FRANCISCO CA 94080 650-487-6488
Akero Therapeutics, Inc. (Filer) CIK: 0001744659 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38944 | Film No.: 221138214
SIC: 2834 Pharmaceutical Preparations